Abstract
Acute clinical toxicity of halogenated oxyquinolines in dogs has been reported (Schantz & Wikström 1965, Hangartner 1965, Müller 1967). The clinical picture was comprehensively studied (Lannek 1972 b). The dose range in the clinical material was found to vary from about 7 to 250 mg per kg body weight (Lannek 1972 a).
Full Text
The Full Text of this article is available as a PDF (197.2 KB).
Footnotes
Supported by grants from Statens Medicinska Forskningsråd.
References
- Hangartner P. Troubles nerveux observés chez le chien après absorption d’Entéro-Vioforme Giba. (Nervous disturbances in the dog after Entero-Vioform Giba absorption). Schweiz. Arch. Tierheilk. 1965;107:43–47. [Google Scholar]
- Lannek, B.: 1972 a. To be published.
- Lannek, B.: 1972 b. To be published.
- Lannek B, Lindberg P. Vioformförgiftning hos hund. (Vioform poisoning in dogs. The absorption of Vioform from the intestine). Svensk Vet.-Tidn. 1972;24:438–441. [Google Scholar]
- Müller L. F. Die Mexaformvergiftung des Hundes (Klinische Demonstration). (Mexaform poisoning of the dog. Clinical demonstration). Kleintier-Prax. 1967;12:51–52. [Google Scholar]
- Obermayer, F.: Verhandlungen ärtzlicher Gesellschaften und Vereine. Wien. klin. Wschr. 1890, 3, 176.
- Schantz B, Wikström B. Misstänkt oxikinolinförgiftning hos hundan (Suspected poisoning with oxyquinoline preparations in dogs). Svensk Vet.-Tidn. 1965;17:106–107. [Google Scholar]
